Skip links

ClariCardio

AI-Assisted Cardio-Metabolic Risk Assessment for Chest CT Screening

ClariCardio  Korea-MFDS-logo

  • ClariCardio is an AI-assisted heart risk assessment solution with chest CT scan.
  • ClariCardio supports quantitative risk scoring with precise measurement of key imaging biomarkers.
  • Beneficial for prevention & management of cardio-metabolic diseases

ClariCardio Benefits

Compliant with DICOM

Compatible with any DICOM standard CT data & PACS system

Fully Automated

Fully-automatic cardio-metabolic health assessment & quantitative reporting

Simple & Fast

Simple installation and fast operation

Vendor Agnostic & Applicable

Vendor-agnostic & applicable to both standard and low-dose CT scan

CVD Risk Markers

  • Epicardial Adipose Tissue (EAT) Volume
  • Thoracic Aorta Calcium (TAC) Volume
  • Coronary Artery Calcium Scoring (CACS)

Flexibility

  • ECG-Gated Cardiac CT
  • Low-Dose Chest CT

Precise CACS

  • Sensitivity > 99 %
  • Specificity > 99%
  • Карра > 0.98
  • ICC > 0.99

Intuitive Reports

  • Coronary Artery Calcification Scoring (CACS)
  • Epicardial Adipose Tissue (EAT) Analysis
  • Thoracic Aorta Calcification Scoring (TACS)
  • Calcified Plaque in Thoracic Aorta and Aortic Valve
  • Main Artery Enlargement Analysis

How It Works

ClariCardio is fully compliant with all DICOM standard CTs and PACS systems, enabling easy and seamless integration.

Transmission Through DICOM

Any CT Scanners

Transmission Through DICOM

  ClariCardio (Quantitative Report)

PACS